Director/PDMR Shareholding
Updated : 12:27
Director/PDMR Shareholding
Oxford, UK - 6 December 2019: Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today announces that on 5 December 2019, Garry Watts, who will be appointed as Senior Independent Director to the Board of Circassia on 2 March 2020, purchased 477,340 Ordinary Shares on the London Stock Exchange at a price of 21.0 pence per share.
Contacts
Circassia Steve Harris, Chief Executive Officer Julien Cotta, Chief Financial Officer Rob Budge, Corporate Communications
| Tel: +44 (0)1865 405560
|
Peel Hunt (Nominated Adviser and Joint Broker) James Steel / Dr Christopher Golden
| Tel: +44 (0) 20 7418 8900
|
finnCap (Joint Broker) Geoff Nash / Alice Lane | Tel: +44 (0) 20 7220 0500 |
Numis Securities (Joint Broker) James Black / Freddie Barnfield
| Tel: +44 (0) 20 7260 1000
|
FTI Consulting Simon Conway / Ciara Martin | Tel: +44 (0) 20 3727 1000
|
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a. | Name | Garry Watts | ||||
2. | Reason for the notification | |||||
a. | Position/status | Director Designate | ||||
b. | Initial notification /Amendment
| Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a. | Name | Circassia Pharmaceuticals plc | ||||
b. | LEI | 2138006YAT138TOGA556 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a. | Description of the Financial instrument, type of instrument Identification code | Ordinary Shares of 0.08p each
GB00BJVD3B28 | ||||
b. | Nature of the transaction | Purchase of Ordinary Shares
| ||||
c. | Price(s) and volume(s) |
| ||||
d. | Aggregated information · Aggregated volume · Price
|
n/a
| ||||
e. | Date of the transaction | 05/12/2019 | ||||
f. | Place of the transaction | London Stock Exchange, AIM
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.